Rosetta Engine for Anchoring Ligands with a Motif is introduced, a screening algorithm that uses structural interaction data from the Protein Data Bank to guide ligand placement and selection and is readily adaptable to the thousands of zebrafish proteins with highly conserved binding pockets.
Abstract
Virtual screening of ultra-large chemical libraries is a highly effective strategy for early-stage ligand discovery. However, these pipelines often yield thousands of molecules that pass computational filters, and in silico-derived interaction energies do not consistently predict experimental efficacy. Furthermore, many high-affinity hits do not necessarily function effectively in an organism with tissues, barriers, and extensive off-target possibilities. Here, we establish and apply an integrated pipeline that prioritizes candidate molecules through structure-guided computation and zebrafish-based functional profiling. We introduce Rosetta Engine for Anchoring Ligands with a Motif (“REAL-M”), a screening algorithm that uses structural interaction data from the Protein Data Bank (PDB) to guide ligand placement and selection. Using the hypocretin receptor as a test case, 28 of 30 predicted antagonists significantly blocked binding of the cognate peptide agonist in a cell-based reporter assay, including six chemically diverse molecules with efficacy comparable to preexisting antagonists. Three of these six significantly mitigated hypocretin-induced larval zebrafish hyperactivity. Secondary testing with a zebrafish hcrtr2 null mutant ensured that behavioral phenotypes were on target, in contrast to off-target phenotypes observed with a clinically approved antagonist. This pipeline is readily adaptable to the thousands of zebrafish proteins with highly conserved binding pockets.
A comprehensive assessment based on systematic benchmarking using a diverse set of class A G-protein-coupled receptors and different approaches to represent protein–ligand demonstrates that the combined approach overall improves the efficacy bias of selected ligands as compared to docking alone.
Luca Chiesa, G. Bret, Severine Schneider et al.· Journal of Chemical Informat...· 0 citations
FlexAutoDock is an automated cloud-based molecular docking platform that provides a unified environment for protein-ligand docking and large-scale virtual screening, providing researchers with an accessible computational resource for accelerating early-stage drug discovery.
Md. Feroj Ahmed, M. Faysal, Khalid Muntasir Sawad et al.· bioRxiv· 0 citations
An AI-enhanced virtual screening pipeline delivered selective SV2C ligands from a general chemical library, providing tools to probe SV2C biology in Parkinson’s disease.
Alexander C. Brueckner, Matthew F. Martin, Sheenam Khuttan et al.· bioRxiv· 0 citations
Although affinity prediction of protein–ligand binding remains an important challenge, cofolding models are expected to make virtual screening more effective for drug discovery and development. To verify the effectiveness of selecting a tractable number of candidates from a compound library using cofolding models, we s...
Shinya Kawano, Akira Ikari, Satoshi Endo et al.· Journal of Chemical Informat...· 0 citations
The results support a staged screening design in which a pooled default is followed by ligand-specific calibration and expert review, and SCScore showed the highest association with the blinded consensus, but performance varied by ligand.
T. Sobodu, Victor Chibuzor Johnson, Ryan Kern et al.· 0 citations
MolDockLab addresses the challenge of structure-based virtual screening with an automated, data-driven framework that optimizes SBVS workflows for a protein target, balancing predictive performance and computational efficiency.
Hamza Agha, Y. Ibrahim, Michael Backenköhler et al.· npj Drug Discovery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.